Statins for primary prevention of venous thromboembolism-Reference-Cited by-同舟云学术

Statins for primary prevention of venous thromboembolism

Published:2014-12-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Li Lun¹,Zhang Peizhen²,Tian Jin Hui³,Yang KeHu⁴

Affiliation:

1. Lanzhou University; The First Clinical College of Lanzhou University; Evidence-Based Medicine Center, School of Basic Medical Sciences; No. 199, Donggang West Road Lanzhou City Gansu China 730000

2. Hospital of Lanzhou City; Maternity and Child-care; West Shizi Lanzhou City Ganshu China 730000

3. Lanzhou University; Evidence-Based Medicine Center, School of Basic Medical Sciences; No. 199, Donggang West Road Lanzhou City Gansu China 730000

4. Lanzhou University; Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province; No. 199, Donggang West Road Lanzhou City Gansu China 730000

Publisher

Wiley

Subject

Pharmacology (medical)

Reference110 articles.

1. AstraZeneca A randomized, double-blind, placebo controlled, multicenter, phase 3 study of rosuvastatin (CRESTOR®) 20 mg in the prevention of cardiovascular events among subjects with low levels of LDL cholesterol and elevated levels of C-reactive protein http://clinicaltrials.gov/ct2/show/NCT00239681

2. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER);Everett;Circulation,2010

3. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study;Fonseca;Expert Review Cardiovascular Therapy,2009

4. A randomized trial of rosuvastatin in the prevention of venous thromboembolism;Glynn;New England Journal of Medicine,2009

5. Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial;Glynn;Annals of Internal Medicine,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statins and Venous Thromboembolic Disease – Where are we Now?;Current Vascular Pharmacology;2024-07

2. Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation;Clinical Transplantation;2022-09-20

3. Perioperative prevention of thrombohemorrhagic complications in patients with calculous cholecystitis and obstructive jaundice;Grekov's Bulletin of Surgery;2022-05-25

4. Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study;Thrombosis Journal;2021-06-27

5. COVID-19 and Thromboinflammation: Is There a Role for Statins?;Clinics;2021